Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis

Journal of Hepatology

Volumn 50, Issue 1, 2009, Pages 150-157

  Henckaerts, Liesbet ^a   Jaspers, Martine ^b   Van Steenbergen, Werner ^a   Vliegen, Liesbet ^b   Fevery, Johan ^a   Nuytten, Hilde ^b   Roskams, Tania ^a   Rutgeerts, Paul ^a   Cassiman, Jean Jacques ^b   Vermeire, Séverine ^a   Cuppens, Harry ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Biliary tract diseases; Disease susceptibility; Genetics; Membrane proteins; Pattern recognition receptors

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENTERITIS; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCLEROSING CHOLANGITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 56949083881     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.07.033     Document Type: Article

References (35)

1. Worthington J., and Chapman R. Primary sclerosing cholangitis. Orphanet J Rare Dis 1 (2006) 41
2. Levy C., and Lindor K.D. Primary sclerosing cholangitis: epidemiology, natural history, and prognosis. Semin Liver Dis 26 (2006) 22-30
3. Wiesner R.H., and Larusso N.F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 79 (1980) 200-206
4. Cullen S., and Chapman R. Primary sclerosing cholangitis. Autoimmun Rev 2 (2003) 305-312
5. Maggs J.R., and Chapman R.W. Sclerosing cholangitis. Curr Opin Gastroenterol 23 (2007) 310-316
6. Davis P.B. Cystic fibrosis since 1938. Am J Respir Crit Care Med 173 (2006) 475-482
7. Bodian M. Fibrocystic disease of the pancreas. First Edition (1952), William Heinemann, London
8. Blanco P.G., Zaman M.M., Junaidi O., Sheth S., Yantiss R.K., Nasser I.A., et al. Induction of colitis in cftr-/- mice results in bile duct injury. Am J Physiol Gastrointest Liver Physiol 287 (2004) G491-G496
9. Sheth S., Shea J.C., Bishop M.D., Chopra S., Regan M.M., Malmberg E., et al. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet 113 (2003) 286-292
10. Pall H., Zielenski J., Jonas M.M., Da Silva D.A., Potvin K.M., Yuan X.W., et al. Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function. J Pediatr 151 (2007) 255-259
11. McGill J.M., Williams D.M., and Hunt C.M. Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis. Dig Dis Sci 41 (1996) 540-542
12. Girodon E., Sternberg D., Chazouilleres O., Cazeneuve C., Huot D., Calmus Y., et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis. J Hepatol 37 (2002) 192-197
13. Neri T.M., Cavestro G.M., Seghini P., Zanelli P.F., Zanetti A., Savi M., et al. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population. Dig Liver Dis 35 (2003) 571-576
14. Gallegos-Orozco J.F., Yurk C.E., Wang N., Rakela J., Charlton M.R., Cutting G.R., et al. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. Am J Gastroenterol 100 (2005) 874-878
15. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
16. Verhelst A, Matthijs G, Verellen-Dumoulin C, Adamis S, De Vreese K, Bläser M., et al. Validation of new line probe assay for the simultaneous detection of CFTR gene mutations and the Tn variants. Abstract presented at the 27th European Cystic Fibrosis Conference, June, 11-13, 2004, Birmingham, UK.
17. Rommens J.M., Iannuzzi M.C., Kerem B.S., Drumm M.L., Melmer G., Dean M., et al. Identification of the cystic-fibrosis gene - chromosome walking and jumping. Science 245 (1989) 1059-1065
18. Riordan J.R., Rommens J.M., Kerem B.S., Alon N., Rozmahel R., Grzelczak Z., et al. Identification of the cystic-fibrosis gene - cloning and characterization of complementary-DNA. Science 245 (1989) 1066-1072
19. Kerem B.S., Rommens J.M., Buchanan J.A., Markiewicz D., Cox T.K., Chakravarti A., et al. Identification of the cystic-fibrosis gene - genetic-analysis. Science 245 (1989) 1073-1080
20. Cuppens H., Loumi O., Marynen P., and Cassiman J.J. Identification of a new frameshift mutation and a duplication polymorphism in the CFTR gene in the Algerian population. Hum Mol Genet 1 (1992) 283-284
21. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
22. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
23. Stephens M., and Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 (2003) 1162-1169
24. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B 57 (1995) 289-300
25. Davies J.C., Alton E.W., and Bush A. Cystic fibrosis. BMJ 225 (2007) 1255-1259
26. Cohn J.A., Strong T.V., Picciotto M.R., Nairn A.C., Collins F.S., and Fitz J.G. Localization of the cystic-fibrosis transmembrane conductance regulator in human bile-duct epithelial-cells. Gastroenterology 105 (1993) 1857-1864
27. Schwiebert E.M., Benos D.J., Egan M.E., Stutts M.J., and Guggino W.B. CFTR is a conductance regulator as well as a chloride channel. Physiol Rev 79 (1999) 145-166
28. Schroeder T.H., Lee M.M., Yacono P.W., Cannon C.L., Gerceker A.A., Golan D.E., et al. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci USA 99 (2002) 6907-6912
29. Pier G.B., Grout M., Zaidi T., Meluleni G., Mueschenborn S.S., Banting G., et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393 (1998) 79-82
30. Lyczak J.B., and Pier G.B. Salmonella enterica serovar typhi modulates cell surface expression of its receptor, the cystic fibrosis transmembrane conductance regulator, on the intestinal epithelium. Infect Immun 70 (2002) 6416-6423
31. Bradbury N.A., Jilling T., Berta G., Sorscher E.J., Bridges R.J., and Kirk K.L. Regulation of plasma-membrane recycling by Cftr. Science 256 (1992) 530-532
32. Chu C.S., Trapnell B.C., Curristin S., Cutting G.R., and Crystal R.G. Genetic-basis of variable exon-9 skipping in cystic-fibrosis transmembrane conductance regulator messenger-RNA. Nat Genet 3 (1993) 151-156
33. Cuppens H., Lin W., Jaspers M., Costes B., Teng H., Vankeerberghen A., et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 101 (1998) 487-496
34. Henckaerts L., Fevery J., Van Steenbergen W., Verslype C., Yap P., Nevens F., et al. CC-type chemokine receptor 5-Delta 32 mutation protects against primary sclerosing cholangitis. Inflamm Bowel Dis 12 (2006) 272-277
35. Seksik P., Sokol H., Lepage P., Vasquez N., Manichanh C., Mangin I., et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 24 (2006) 11-18